Standout Papers

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2006 2026 2012 2019 2.4k
  1. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis (2006)
    Chris H. Polman, Paul O’Connor et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 17 from Science/Nature 68 standout
Sub-graph 1 of 17

Citing Papers

CAR T therapy beyond cancer: the evolution of a living drug
2023 StandoutNature
Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma
2021 StandoutScience
7 intermediate papers

Works of A Wajgt being referenced

The incidence and significance of anti-natalizumab antibodies
2007
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout

Author Peers

Author Last Decade Papers Cites
A Wajgt 2476 807 1236 857 35 3.3k
Gavin Giovannoni 2955 1049 1194 928 62 3.6k
Jeffrey Cohen 2387 914 764 690 51 2.9k
Frances Lynn 3556 1153 1839 1109 18 4.6k
K. P. Johnson 2434 1165 642 1036 40 3.6k
J. S. Wolinsky 2756 1324 603 747 37 3.3k
Joanne Jones 1806 923 776 1329 63 3.5k
Mark S. Freedman 2825 1324 620 482 44 3.4k
Marcelo Kremenchutzky 2408 972 644 350 63 3.1k
J. A. Cohen 2413 1132 522 586 23 2.9k
Craig H. Smith 2317 961 698 1625 11 3.3k

All Works

Loading papers...

Rankless by CCL
2026